StockData
ELI LILLY & Co logo

ELI LILLY & Co (LLY) operating KPIs

LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1417.54+43.84 (+3.19%)

Close on Oct 30, 2026Market cap $1.33TP/E 46.0Yield 0.44%

Eli Lilly cialis (tadalafil) — Worldwide revenue ($M) [legacy separate disclosure] ($M)

Form 10-Q / 10-K Note 2 & MD&A (legacy separate product disclosure prior to FY2025 reorganization)

QuarterlyAnnual
Latest, Q3 2024
91.5
Period ended Sep 30, 2024
Change on a year earlier
+5.4%
86.8 in Q3 2023
History
31 quarters
Since Q1 2017
Sources
28
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedCialis (tadalafil) — Worldwide revenue ($M) [legacy separate disclosure] ($M)Year on yearSource
Q3 2024Sep 30, 202491.5+5.4%Form 10-Q (filed 2024-10-30) ↗
Q2 2024Jun 30, 202487.7-24.1%Form 10-Q (filed 2024-08-08) ↗
Q1 2024Mar 31, 2024139+38.9%Form 10-Q (filed 2024-04-30) ↗
Q4 2023Dec 31, 202378.8-26.3%Form 10-K FY2023 (filed 2024-02-21) ↗
Q3 2023Sep 30, 202386.8-25.0%Form 10-Q (filed 2024-10-30) ↗
Q2 2023Jun 30, 2023116-21.4%Form 10-Q (filed 2024-08-08) ↗
Q1 2023Mar 31, 2023100-53.9%Form 10-Q (filed 2024-04-30) ↗
Q4 2022Dec 31, 2022107-40.5%Form 10-K FY2022 (filed 2023-02-22) ↗
Q3 2022Sep 30, 2022116-11.6%Form 10-Q (filed 2023-11-02) ↗
Q2 2022Jun 30, 2022147-47.7%Form 10-Q (filed 2023-08-08) ↗
Q1 2022Mar 31, 2022218+71.7%Form 10-Q (filed 2023-04-27) ↗
Q4 2021Dec 31, 2021180+48.6%Form 10-K FY2021 (filed 2022-02-23) ↗
Q3 2021Sep 30, 2021131-19.4%Form 10-Q (filed 2022-11-01) ↗
Q2 2021Jun 30, 2021281+115.0%Form 10-Q (filed 2022-08-04) ↗
Q1 2021Mar 31, 2021127-34.3%Form 10-Q (filed 2022-04-29) ↗
Q4 2020Dec 31, 2020121-89.6%Form 10-K FY2020 (filed 2021-02-17) ↗

Breakdown

What makes up cialis (tadalafil) — worldwide revenue ($m) [legacy separate disclosure]

Cite this data

StockData. (2026). Eli Lilly Cialis (tadalafil) — Worldwide revenue ($M) [legacy separate disclosure] ($M), quarterly Q1 2017–Q3 2024 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/med_cialis_ww

See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.